Procainamide

This is a type of medicine called an antiarrhythmic. It's used to help control irregular heartbeats. It works by affecting the electrical signals in your heart muscle.

Brand names:Procan, Procanbid, Pronestyl
Medication

What people taking Procainamide report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Procainamide

What It's For

Procainamide is an antiarrhythmic medicine, a drug that steadies an abnormal heart rhythm. In the US it is approved for documented ventricular arrhythmias that a physician judges to be life-threatening, such as sustained ventricular tachycardia (VT), a fast rhythm that starts in the heart's lower chambers and can lead to collapse. Emergency teams often use it when VT is fast but blood pressure is holding up, because there is time to try medicine before an electrical shock. Doctors also use it outside its US label. Some emergency departments, particularly in Canada, give it to restore a normal rhythm in recent-onset atrial fibrillation, an irregular rhythm in the upper chambers. Heart rhythm specialists also use a monitored procainamide infusion as a diagnostic test for Brugada syndrome, an inherited rhythm condition: the drug can bring out a telltale ECG (electrocardiogram) pattern that is otherwise hidden. Today procainamide is a hospital medicine. Tablets and capsules once sold as Procan SR, Procanbid and Pronestyl, plus their generics, are all discontinued in the US, so long-term treatment at home now relies on other rhythm medicines.

How It Works

Each heartbeat is triggered by an electrical signal that spreads through the heart muscle, carried partly by sodium moving into heart cells. Procainamide blocks some of those sodium channels, which slows how fast the signal travels and makes heart cells take longer to recover before they can fire again. A rapid rhythm often depends on a signal racing around a loop or a small area firing out of turn; slowing and stabilizing the signal can break that loop and let the heart's normal pacemaker take back control. It belongs to the same group of rhythm medicines (class 1A) as quinidine, an older drug: class 1A drugs both slow the signal and lengthen the heart cells' recovery time. The liver converts part of each dose into NAPA (N-acetylprocainamide), which also affects heart rhythm, and both are cleared mainly by the kidneys. This is why kidney function and age shape how much a person needs.

Dosage & Administration

Procainamide is given into a vein (IV), or occasionally as an injection into a muscle, in a hospital or emergency setting. The team gives it slowly, either as small repeated doses or as a loading infusion over about half an hour, and may follow with a continuous drip to keep levels steady. Throughout, a heart monitor shows the rhythm and blood pressure is checked often. The dose is based on body weight, response and ECG changes rather than a fixed amount. Lower doses or slower infusions are often needed for people with kidney disease and for older adults, because the drug and NAPA build up when the kidneys clear them more slowly. If treatment continues for more than a short period, the team may measure blood levels of procainamide and NAPA to guide the dose.

Side Effects

During the infusion, the most important effect is a drop in blood pressure, which can cause lightheadedness or feeling faint. The team watches for this and slows or pauses the drip if blood pressure falls. Like other rhythm medicines, procainamide can sometimes provoke a new or worse abnormal rhythm or slow the heart's electrical conduction too much, which is the main reason it is only given with continuous heart monitoring. Nausea, a bitter taste, dizziness and rash can also occur. A rare but serious effect is a sharp fall in white blood cells, which fight infection, or in platelets, which help blood clot. It was reported in roughly 1 in 200 people, mainly during repeated or continued treatment, can be fatal, and most often appears within the first 12 weeks. Fever, chills, a sore throat, mouth sores, unusual bruising or bleeding after receiving procainamide should prompt a call to the care team right away so a blood count can be checked. Liver inflammation has also been reported, so dark urine or yellowing skin or eyes are worth reporting.

Interactions & Warnings

Procainamide carries an FDA boxed warning about a lupus-like reaction. With prolonged use it often causes a positive ANA (antinuclear antibody) test, a blood marker of the immune system targeting the body's own tissues. Some people go on to develop a syndrome that resembles lupus: joint and muscle aches, fever, and chest pain from inflammation around the lungs or heart. This was seen mainly with months of treatment by mouth, which is no longer available in the US, so it is much less of a concern after a short hospital course. When it happens, the usual step is stopping the drug; if procainamide has to be continued for a dangerous rhythm that nothing else controls, steroids may be used to control the symptoms. Because it can make lupus worse, people with systemic lupus erythematosus are not given procainamide. It is also not used in complete heart block (when signals from the upper chambers do not reach the lower chambers) or in torsades de pointes, a twisting form of VT linked to a long QT interval (a sign on the ECG that the heart is slow to recharge between beats), which it can worsen. Caution is needed in heart failure, other conduction problems and kidney disease. It can worsen myasthenia gravis, a condition that causes muscle weakness. The injection contains a sulfite preservative that can cause allergic-type reactions in sensitive people, especially some with asthma. Using it with other antiarrhythmic medicines, such as quinidine or disopyramide, can add to the effects on heart rhythm and blood pressure. It can also strengthen the effect of muscle relaxants used during anesthesia, such as succinylcholine. Tell the team about any reaction to procaine or other numbing medicines. Its safety in pregnancy is not known, so it is used only when clearly needed, and it passes into breast milk.

What to Expect

When procainamide is given for a fast rhythm, the effect is watched in real time on the monitor. If it is going to work, the effect usually shows within the first half hour or so after the loading dose. If it does not, the team may move to an electrical cardioversion (a timed shock under sedation) or another medicine. In a trial of people with stable VT, IV procainamide stopped the rhythm within 40 minutes in about two-thirds of patients. For recent-onset atrial fibrillation in a Canadian trial, it restored normal rhythm in about half. Procainamide controls a rhythm in the moment; like other antiarrhythmic drugs, it has not been shown to help people live longer. After the episode, attention turns to why it happened and how to prevent the next one, which may involve a different long-term medicine or a heart rhythm procedure, depending on the cause. For a Brugada test, the infusion lasts a short time under monitoring and the ECG is reviewed for the characteristic pattern; in a large Canadian registry, serious rhythm problems during testing were very rare.

Questions to Ask Your Doctor

  1. 1.Why was procainamide chosen for my rhythm instead of amiodarone (another rhythm medicine) or an electrical cardioversion?
  2. 2.Did the medicine work, and what treatment will prevent this rhythm from coming back now that I am leaving the hospital?
  3. 3.Do I need blood counts or other tests in the coming weeks, and which symptoms should make me call?
  4. 4.Does my kidney function, lupus history or myasthenia gravis change whether this drug is safe for me?
  5. 5.If I had a Brugada test, what does a positive or negative result mean for me and my family?

Last reviewed • Oct 2026

Educational content, not medical advice.